Activating CBL mutations are associated with a distinct MDS/MPN phenotype (Q33403530)

26 July 2017

title

Activating CBL mutations are associated with a distinct MDS/MPN phenotype (English)

1 reference

26 July 2017

1 reference

Andreas Hochhaus

0 references

Torsten Haferlach

1 reference

26 July 2017

Georgia Metzgeroth

1 reference

26 July 2017

Susanne Schnittger

1 reference

26 July 2017

Juliana Schwaab

1 reference

26 July 2017

Philipp Erben

1 reference

26 July 2017

Wolf-Karsten Hofmann

1 reference

26 July 2017

Thomas Ernst

1 reference

26 July 2017

Jenny Rinke

1 reference

26 July 2017

Philipp Ströbel

1 reference

26 July 2017

Max Mossner

1 reference

26 July 2017

Nicholas C P Cross

1 reference

26 July 2017

Andreas Reiter

1 reference

26 July 2017

publication date

10 August 2012

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

1713-1720

1 reference

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Mutations in CBL occur frequently in juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

The Cbl family proteins: ring leaders in regulation of cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Beyond the RING: CBL proteins as multivalent adapters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

The Cbl interactome and its functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Alix facilitates the interaction between c-Cbl and platelet-derived growth factor beta-receptor and thereby modulates receptor down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1521-3

10.1007/S00277-012-1521-3

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference